2023 Q1 Form 10-K Financial Statement
#000162828023008931 Filed on March 22, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $1.725M | $1.847M | $8.256M |
YoY Change | -25.09% | 1.5% | 0.03% |
Cost Of Revenue | $526.4K | $617.3K | $2.506M |
YoY Change | 3.44% | 6.89% | 7.46% |
Gross Profit | $1.198M | $1.230M | $5.750M |
YoY Change | -33.18% | -1.01% | -2.89% |
Gross Profit Margin | 69.48% | 66.59% | 69.65% |
Selling, General & Admin | $2.209M | $1.548M | $7.252M |
YoY Change | 8.03% | 23.85% | 29.28% |
% of Gross Profit | 184.33% | 125.86% | 126.12% |
Research & Development | $699.4K | $538.4K | $3.240M |
YoY Change | -1.57% | -46.0% | 24.78% |
% of Gross Profit | 58.36% | 43.77% | 56.34% |
Depreciation & Amortization | $10.22K | $10.22K | $49.39K |
YoY Change | -20.62% | -137.56% | -35.33% |
% of Gross Profit | 0.85% | 0.83% | 0.86% |
Operating Expenses | $2.908M | $2.087M | $10.49M |
YoY Change | 5.55% | -7.15% | 27.85% |
Operating Profit | -$1.710M | -$856.5K | -$4.742M |
YoY Change | 77.76% | -14.73% | 107.55% |
Interest Expense | $325.2K | ||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $135.9K | $164.6K | $325.2K |
YoY Change | 3862.1% | 11021.62% | 10222.54% |
Pretax Income | -$1.574M | -$691.9K | -$4.417M |
YoY Change | 64.22% | -31.02% | 93.59% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.574M | -$691.9K | -$4.417M |
YoY Change | 64.22% | -31.02% | 93.59% |
Net Earnings / Revenue | -91.27% | -37.45% | -53.5% |
Basic Earnings Per Share | -$0.20 | -$0.62 | |
Diluted Earnings Per Share | -$0.20 | -$0.09 | -$0.62 |
COMMON SHARES | |||
Basic Shares Outstanding | 7.792M shares | 7.757M shares | 7.130M shares |
Diluted Shares Outstanding | 7.689M shares | 7.130M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $20.25M | $21.20M | $21.20M |
YoY Change | -14.79% | -6.08% | -6.08% |
Cash & Equivalents | $2.377M | $21.20M | $21.20M |
Short-Term Investments | $17.88M | $16.95M | $16.95M |
Other Short-Term Assets | $508.4K | $2.907M | $2.907M |
YoY Change | 20.29% | 385.86% | 385.86% |
Inventory | $1.748M | $1.615M | $1.615M |
Prepaid Expenses | |||
Receivables | $576.3K | $646.8K | $646.8K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $23.09M | $24.11M | $24.11M |
YoY Change | -9.77% | -0.33% | -0.33% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $155.4K | $165.6K | $536.2K |
YoY Change | -15.7% | -16.65% | -20.43% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $26.40K | $562.6K | $562.6K |
YoY Change | 0.0% | 2031.17% | 2031.17% |
Total Long-Term Assets | $523.9K | $562.6K | $562.6K |
YoY Change | -20.76% | -19.66% | -19.66% |
TOTAL ASSETS | |||
Total Short-Term Assets | $23.09M | $24.11M | $24.11M |
Total Long-Term Assets | $523.9K | $562.6K | $562.6K |
Total Assets | $23.61M | $24.67M | $24.67M |
YoY Change | -10.05% | -0.88% | -0.88% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $400.3K | $368.1K | $368.1K |
YoY Change | 10.93% | 29.59% | 29.59% |
Accrued Expenses | $868.3K | $589.9K | $738.3K |
YoY Change | -28.06% | -27.54% | -31.74% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.417M | $1.106M | $1.106M |
YoY Change | -17.96% | -18.99% | -18.99% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $180.4K | $207.5K | $207.5K |
YoY Change | -36.32% | -32.34% | -32.34% |
Total Long-Term Liabilities | $180.4K | $207.5K | $207.5K |
YoY Change | -36.32% | -32.34% | -32.34% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.417M | $1.106M | $1.106M |
Total Long-Term Liabilities | $180.4K | $207.5K | $207.5K |
Total Liabilities | $1.597M | $1.314M | $1.314M |
YoY Change | -20.55% | -21.43% | -21.43% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$205.2M | -$203.6M | |
YoY Change | 2.51% | 2.22% | |
Common Stock | $778.00 | $778.00 | |
YoY Change | 10.98% | 16.29% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $22.01M | $23.36M | $23.36M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $23.61M | $24.67M | $24.67M |
YoY Change | -10.05% | -0.88% | -0.88% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.574M | -$691.9K | -$4.417M |
YoY Change | 64.22% | -31.02% | 93.59% |
Depreciation, Depletion And Amortization | $10.22K | $10.22K | $49.39K |
YoY Change | -20.62% | -137.56% | -35.33% |
Cash From Operating Activities | -$1.121M | -$1.483M | -$5.289M |
YoY Change | 51.46% | 189.39% | 155.07% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | $23.18K |
YoY Change | -100.0% | -100.0% | -82.4% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$837.0K | $2.051M | -$16.87M |
YoY Change | |||
Cash From Investing Activities | -$837.0K | $2.051M | -$16.89M |
YoY Change | 15414.07% | -30851.27% | 12726.25% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $0.00 | 1.913M | $3.864M |
YoY Change | -100.0% | -1664.18% | -80.24% |
NET CHANGE | |||
Cash From Operating Activities | -$1.121M | -1.483M | -$5.289M |
Cash From Investing Activities | -$837.0K | 2.051M | -$16.89M |
Cash From Financing Activities | $0.00 | 1.913M | $3.864M |
Net Change In Cash | -$1.958M | 2.481M | -$18.32M |
YoY Change | -263.57% | -486.83% | -205.61% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.121M | -$1.483M | -$5.289M |
Capital Expenditures | $0.00 | $0.00 | $23.18K |
Free Cash Flow | -$1.121M | -$1.483M | -$5.313M |
YoY Change | 50.37% | 193.21% | 140.89% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001289850 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | us-gaap |
Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
|
false | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
NURO | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
25918726 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7791538 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
23 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Baker Tilly US, LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Tewksbury, Massachusetts | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4253268 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22572104 | usd |
CY2022Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
16946459 | usd |
CY2021Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
0 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
646771 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
310818 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1614987 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
706553 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
645502 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
598384 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
24106987 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
24187859 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
165619 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
198703 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
370609 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
475230 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
26400 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
26400 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
24669615 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
24888192 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
368082 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
284036 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
589939 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
853155 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
148391 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
228506 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1106412 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1365697 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
207516 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
306709 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
1313928 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
1672406 | usd |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7785754 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7785754 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6680480 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6680480 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
778 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
226934774 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
222378373 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-203579866 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-199163257 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23355687 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23215786 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24669615 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24888192 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
8256073 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
8253493 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2331833 | usd |
CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2865615 | usd |
CY2021 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1619711 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4386666 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3990141 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
10492006 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
8206267 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4741766 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2284607 | usd |
CY2022 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
325157 | usd |
CY2021 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
3150 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4416609 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4416609 | usd |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2281457 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2281457 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.62 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.62 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.45 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.45 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5247775 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
698173 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
19429621 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
78500 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
43174 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2281457 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23215786 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
477062 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3833772 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
215417 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
30259 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4416609 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23355687 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-4416609 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-2281457 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
49391 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
76378 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
477062 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
698173 | usd |
CY2022 | nuro |
Research And Development Write Off
ResearchAndDevelopmentWriteOff
|
0 | usd |
CY2021 | nuro |
Research And Development Write Off
ResearchAndDevelopmentWriteOff
|
400000 | usd |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
356700 | usd |
CY2021 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
99141 | usd |
CY2022 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-6875 | usd |
CY2021 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-40123 | usd |
CY2022 | nuro |
Interest Income Accretion Held To Maturity Securities
InterestIncomeAccretionHeldToMaturitySecurities
|
76190 | usd |
CY2021 | nuro |
Interest Income Accretion Held To Maturity Securities
InterestIncomeAccretionHeldToMaturitySecurities
|
0 | usd |
CY2022 | nuro |
Compensation Obligation Settlement
CompensationObligationSettlement
|
26019 | usd |
CY2021 | nuro |
Compensation Obligation Settlement
CompensationObligationSettlement
|
0 | usd |
CY2022 | nuro |
Idle Facility Impairment Charge
IdleFacilityImpairmentCharge
|
0 | usd |
CY2021 | nuro |
Idle Facility Impairment Charge
IdleFacilityImpairmentCharge
|
126748 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-23479 | usd |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
154412 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
613300 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
141720 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-630287 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2073694 | usd |
CY2022 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
40933126 | usd |
CY2021 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
0 | usd |
CY2022 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
24062857 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
23182 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
131710 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-131710 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
19551295 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
19551295 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
17345891 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22572104 | usd |
CY2022 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
189398 | usd |
CY2021 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
0 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
21200000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Assumptions</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances and regularly assesses these estimates, but actual results could differ materially from these estimates. Effects of changes in estimates are recorded in the period in which they occur.</span></div> | |
CY2022Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
16877403 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, trade receivables, and held-to-maturity securities. The Company invests its cash equivalents in highly rated institutions.</span></div>At December 31, 2022 and 2021, two customers accounted for 31% and 35% of accounts receivable, respectively. One customer accounted for 32% of revenues for the year ended December 31, 2022 and one customer accounted for 27% of revenues, for the year ended December 31, 2021. | |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4416609 | usd |
CY2022Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
16700 | usd |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
28400 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-4416609 | usd |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2281457 | usd |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2281457 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7130139 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7130139 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5111045 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5111045 | shares |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.62 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.62 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.45 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.45 | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
816505 | shares |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
534107 | shares |
CY2022 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
268703 | usd |
CY2021 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
276263 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | usd |
CY2021 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.14 | |
CY2022 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.14 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.700 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.700 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
504045 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.34 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
21500 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.84 | |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
83 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
165.98 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
525462 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.34 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y9M18D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
481462 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
3.33 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y9M18D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
481462 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.33 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y9M18D | |
CY2022Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
131621 | usd |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
108788 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
37394 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
106493 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
589939 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
853155 | usd |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | usd |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.84 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.93 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | usd |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
449500 | usd |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
76194 | usd |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
44000 | shares |
CY2022Q4 | nuro |
Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Price Per Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAveragePricePerShares
|
3.41 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
477062 | usd |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
698173 | usd |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1057845 | usd |
CY2022 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y1M6D | |
CY2022Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
982129 | usd |
CY2021Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
422093 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
632858 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
284460 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1614987 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
706553 | usd |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
356700 | usd |
CY2021 | nuro |
Research And Development Write Off
ResearchAndDevelopmentWriteOff
|
400000 | usd |
CY2022 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
0 | usd |
CY2021 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
119826 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
846630 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1504843 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
681011 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1306140 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
165619 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
198703 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
49391 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
76378 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
155000 | usd |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
109000 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
249224 | usd |
CY2021Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
440474 | usd |
CY2022Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
16700 | usd |
CY2021Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
28400 | usd |
CY2022Q4 | nuro |
Accrued Leaseholds Current
AccruedLeaseholdsCurrent
|
0 | usd |
CY2021Q4 | nuro |
Accrued Leaseholds Current
AccruedLeaseholdsCurrent
|
60000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.049 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.046 | |
CY2022 | nuro |
Effective Income Tax Rate Reconciliation Impact Of Permanent Differences
EffectiveIncomeTaxRateReconciliationImpactOfPermanentDifferences
|
-0.001 | |
CY2021 | nuro |
Effective Income Tax Rate Reconciliation Impact Of Permanent Differences
EffectiveIncomeTaxRateReconciliationImpactOfPermanentDifferences
|
0.020 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.033 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.020 | |
CY2022 | nuro |
Effective Income Tax Rate Reconciliation382 Limitation
EffectiveIncomeTaxRateReconciliation382Limitation
|
0.174 | |
CY2021 | nuro |
Effective Income Tax Rate Reconciliation382 Limitation
EffectiveIncomeTaxRateReconciliation382Limitation
|
0 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.465 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.296 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3369688 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
2247647 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
310000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
92465 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
74459 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
117795 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
88983 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
23396 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
323337 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
325695 | usd |
CY2022Q4 | nuro |
Deferred Tax Assets Right Of Use Assets
DeferredTaxAssetsRightOfUseAssets
|
87872 | usd |
CY2021Q4 | nuro |
Deferred Tax Assets Right Of Use Assets
DeferredTaxAssetsRightOfUseAssets
|
134950 | usd |
CY2022Q4 | nuro |
Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
|
719888 | usd |
CY2021Q4 | nuro |
Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
5637 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4974227 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
2947585 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4868469 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2827759 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
91502 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
14256 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q4 | nuro |
Income Tax Expense Benefit Attributable To Net Operating Loss Carry Forward
IncomeTaxExpenseBenefitAttributableToNetOperatingLossCarryForward
|
2500000 | usd |
CY2022Q4 | nuro |
Income Tax Expense Benefit Attributable To Tax Credit Carry Forwards
IncomeTaxExpenseBenefitAttributableToTaxCreditCarryForwards
|
75000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4900000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2800000 | usd |
CY2022Q4 | nuro |
Nol And Tax Credit Carryforwards Eliminated
NOLAndTaxCreditCarryforwardsEliminated
|
123800000 | usd |
CY2022 | us-gaap |
Sublease Income
SubleaseIncome
|
22795 | usd |
CY2021 | us-gaap |
Sublease Income
SubleaseIncome
|
125739 | usd |
CY2022 | nuro |
Idle Facility Impairment Charge
IdleFacilityImpairmentCharge
|
0 | usd |
CY2021 | nuro |
Idle Facility Impairment Charge
IdleFacilityImpairmentCharge
|
126748 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
165785 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
165785 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
117431 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
449001 | usd |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.150 | |
CY2022Q4 | nuro |
Operating Lease Discount
OperatingLeaseDiscount
|
93094 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
148391 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
207516 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
449001 | usd |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
163061 | usd |
CY2021 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
201496 | usd |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y2M12D | |
CY2022 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | usd |
CY2021 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | usd |
CY2022 | us-gaap |
Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
|
0 | usd |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7785754 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7785754 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6680480 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6680480 | shares |
CY2022 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. | |
CY2022Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
1101744 | shares |